Therapeutic approaches for ischemia/reperfusion injury in the liver.
about
Gene deletion of P-Selectin and ICAM-1 does not inhibit neutrophil infiltration into peritoneal cavity following cecal ligation-punctureThe hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levelsThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingDifferential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowelReduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition.Neuronal Damage Induced by Perinatal Asphyxia Is Attenuated by Postinjury Glutaredoxin-2 AdministrationInfluence of ezetimibe on selected parameters of oxidative stress in rat liver subjected to ischemia/reperfusionDivergent roles of superoxide and nitric oxide in liver ischemia and reperfusion injury.Identification of differentially expressed genes after partial rat liver ischemia/reperfusion by suppression subtractive hybridization.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisMolecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.Clinical translation of nitrite therapy for cardiovascular diseases.The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses.The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiologyCromoglycate, not ketotifen, ameliorated the injured effect of warm ischemia/reperfusion in rat liver: role of mast cell degranulation, oxidative stress, proinflammatory cytokine, and inducible nitric oxide synthaseThe nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injuryFactors in the pathophysiology of the liver ischemia-reperfusion injury.Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling.Reactive metabolites and AGE-RAGE-mediated inflammation in patients following liver transplantationBlockade of adrenoreceptors inhibits the splenic response to stroke.Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury.CXC chemokines play a critical role in liver injury, recovery, and regeneration.Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention.Medical gases: a novel strategy for attenuating ischemia-reperfusion injury in organ transplantation?Current knowledge on oxidative stress in hepatic ischemia/reperfusion.The role of the spleen in ischemic stroke.Double-Injected Human Stem Cells Enhance Rehabilitation in TBI Mice Via Modulation of Survival and Inflammation.Heme oxygenase-1 protects donor livers from ischemia/reperfusion injury: the role of Kupffer cells.The splenic response to ischemic stroke: what have we learned from rodent models?Antioxidant Activity of SOD and Catalase Conjugated with Nanocrystalline Ceria.Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo.Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats.Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice.Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury.The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusionLiver-lung interactions following Escherichia coli bacteremic sepsis and secondary hepatic ischemia/reperfusion injury.Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury.
P2860
Q24796705-3348612A-490F-456B-94CB-7C00EA086DE4Q28082871-0F59F240-82B2-42BB-BF9A-1A3BD4B78FD8Q28389739-6006005B-98B7-4B2B-9EC0-F832B5A5F10BQ28583062-CB1BBE1B-1419-4B0B-B86B-71178EE29C25Q30435373-47637708-3A07-4148-8BF9-754FC2AA87E1Q32034876-03138E4E-2971-4C4D-8F7F-7E35DE72008CQ33863777-A5610F28-AE8B-4947-9205-40F238BECD4CQ34247195-3C4245CE-4A25-4108-9AC7-833A566420FEQ34496426-B033911F-7F75-4B84-9538-97314910957DQ34605086-3646CC2A-14AC-464E-ADB4-A93723DFE74EQ34655802-268F4CA4-AB6B-4215-BB66-5BA0175D8726Q35028609-729C3D48-789C-40E1-8E0B-58BC057D5E4AQ35686746-29C041FB-F307-46E0-92A4-12EF9AC9BD77Q35751635-3323348B-AD5F-4524-BB3D-DBFC39E76C81Q35977888-A82BC871-7091-4114-9E35-9466DF42428FQ36014368-266794E1-5CDC-45A3-B747-62C48696DEEDQ36079408-4AA74634-F590-4048-ABE6-D39077A87F04Q36403403-AFDF3E0C-F9F3-4B2E-A4E2-D86509D70C26Q36431793-23BF513F-4A98-4E15-B18D-786C8A3FC5FBQ36743874-904E6A6D-FF1C-4D00-A747-BB83CC61B069Q36844600-8A31FB8C-AC90-44CE-9660-7B73489210FBQ36916192-378F0845-1661-4F6D-9691-96E343654609Q37289258-9AA7830E-0A03-4B5D-B750-79CC8FEBD384Q37304773-A9C0EA85-654D-4519-898C-E06F73133D5DQ37589136-19700722-CE70-460F-B6AA-CBCA1505DAACQ37733072-02121957-59FC-4F01-8F00-D8C32C6228AAQ38014439-314BF43C-4D9C-4DE7-9075-35A991FC933AQ38112166-64879DE5-F92F-430F-BD5C-43104D3439D9Q38281288-B2B79E82-E071-4CDD-942B-5E2432188A31Q38400864-DDA5D87E-398B-4B1E-95A8-93AEE6B1B62BQ39638475-9BE439A8-1742-4896-9EBE-08710C96038CQ39712806-83388F7D-2068-4A4B-A3D9-7D33FA2C1992Q41512833-39383917-56A3-4BB1-AAFD-D27D47E6822BQ41769409-C077A319-F823-484F-A38C-7AB6964F2E92Q41862707-3C6FECBF-3C1F-4D19-98E0-9F7DF1F1832FQ42100887-1F0F4DC7-8D8B-4171-A85F-4D9D9BF3E0C9Q42613092-A5CAEA87-682F-4DA0-9908-965235026F92Q42855607-9570062D-3216-4BFE-80B0-499471F26EECQ43422304-7EBB75B0-7B8B-436B-831E-03C8F76D4EE5Q43553598-41B88F0A-B9DC-4132-9F90-4A28FCD75BC9
P2860
Therapeutic approaches for ischemia/reperfusion injury in the liver.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Therapeutic approaches for ischemia/reperfusion injury in the liver.
@ast
Therapeutic approaches for ischemia/reperfusion injury in the liver.
@en
type
label
Therapeutic approaches for ischemia/reperfusion injury in the liver.
@ast
Therapeutic approaches for ischemia/reperfusion injury in the liver.
@en
prefLabel
Therapeutic approaches for ischemia/reperfusion injury in the liver.
@ast
Therapeutic approaches for ischemia/reperfusion injury in the liver.
@en
P356
P1476
Therapeutic approaches for ischemia/reperfusion injury in the liver
@en
P2093
P2888
P304
P356
10.1007/S001099900029
P577
1999-08-01T00:00:00Z
P6179
1021953862